Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the upcoming lead plaintiff deadline on January 16, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Perrigo securities during the specified class period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file with the court by January 16, 2026 [2]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [3]. - The firm has consistently ranked in the top 4 for securities class action settlements since 2013 and recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [3]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including significant underinvestment in maintenance and the need for substantial capital expenditures [4]. - It is claimed that these misstatements led to overstated financial results, including earnings and cash flow, which misled investors about the company's operations and prospects [4].

Group 1: Company Performance - Perrigo Company plc reported third-quarter revenue of $1.04 billion, reflecting a 4.06% decline compared to the same period last year [3] - Operating income for the quarter was $73 million, down from $80 million a year earlier [3] - Despite soft over-the-counter consumption, Perrigo gained dollar, unit, and volume share in five of its seven store-brand categories, indicating strong in-market performance [3] Group 2: Strategic Initiatives - On November 5, Perrigo announced a strategic review of its infant formula business, aiming to shift towards higher-margin branded products [4] - The company is a leading supplier of store-brand baby formula, which has faced challenges due to quality issues at manufacturing facilities [4] Group 3: Market Position and Analyst Ratings - Perrigo is included among the Best Stocks for a Dividend Achievers List, highlighting its position in the market [1] - JPMorgan reduced its price target for Perrigo to $18 from $20 while maintaining a Neutral rating, citing updates to its financial model [2]

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1] Group 1: Allegations of the Lawsuit - The lawsuit claims that Perrigo's acquisition of the infant formula business from Nestlé was significantly underinvested in maintenance and operational improvements [2] - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2] - The complaint points out significant manufacturing deficiencies in the facility related to the infant formula business [2] - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were reportedly overstated [2] - The lawsuit asserts that the positive statements made by the defendants regarding Perrigo's business and prospects were materially misleading and lacked a reasonable basis [2] Group 2: Next Steps for Affected Investors - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request to be appointed as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff to share in any potential recovery [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has a strong track record in high-stakes securities litigation [4] - The firm has over 70 employees dedicated to serving clients and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Perrigo Company plc regarding a class action lawsuit alleging that the company made materially false and misleading statements about its infant formula business, which was acquired from Nestlé, leading to overstated financial results [1]. Group 1: Allegations - The complaint alleges that the infant formula business suffered from significant underinvestment in maintenance, operational improvements, and repairs [1] - Perrigo needed to make substantial capital and operational expenditures beyond the company's stated cost estimates to remediate the infant formula business [1] - There were significant manufacturing deficiencies in the facility for the company's infant formula business [1] - As a result of these issues, the company's financial results, including earnings and cash flow, were overstated [1] - Defendants' positive statements about the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1] Group 2: Class Action Details - The class period for the lawsuit is from February 27, 2023, to November 4, 2025 [1] - Shareholders are encouraged to register for the class action by January 16, 2026, to potentially be appointed as lead plaintiff [2] - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case [2]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, deadline to serve as lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5]. - The deadline to move the Court to serve as lead plaintiff is January 16, 2026, with the lead plaintiff acting on behalf of other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been ranked highly for its performance in securities class action settlements [3]. - The firm has been recognized for its expertise, with founding partner Laurence Rosen named a Titan of Plaintiffs' Bar by Law360 in 2020 [3]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including issues related to underinvestment, necessary capital expenditures, and manufacturing deficiencies [4]. - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were overstated, leading to misleading statements about the company's business prospects [4]. - The lawsuit claims that when the true details became known, investors suffered damages [4].

Core Viewpoint - A class action has been filed against Perrigo Company, alleging that the company misled investors about the value of its infant formula during the specified class period [1] Company Overview - Perrigo Company (NYSE: PRGO) provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally [1] Class Action Details - The class period for the action is from February 27, 2024, to November 4, 2025 [1] - The lawsuit is on behalf of all investors who acquired Perrigo securities during this class period [1]

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific allegations of misleading statements and undisclosed risks impacting their financial performance [1]. Company Summaries Freeport-McMoRan Inc. (NYSE: FCX) - Class Period: February 15, 2022 – September 24, 2025 - Allegations include failure to ensure safety at the Grasberg Block Cave mine, leading to heightened risks of worker fatalities and undisclosed regulatory and reputational risks [2]. Perrigo Company plc (NYSE: PRGO) - Class Period: February 27, 2023 – November 4, 2025 - Allegations focus on significant underinvestment in the infant formula business acquired from Nestlé, requiring substantial capital expenditures for remediation, and overstated financial results [3]. Jayud Global Logistics Limited (NASDAQ: JYD) - Class Period: April 21, 2023 – April 30, 2025 - Allegations include involvement in a fraudulent stock promotion scheme, insider trading activities, and misleading public statements regarding the company's operations and risks [4]. StubHub Holdings, Inc. (NYSE: STUB) - Class Period: September 14, 2025 – November 24, 2025 - Allegations pertain to changes in vendor payment timing adversely affecting free cash flow, leading to materially misleading financial reports [5].

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1] Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's infant formula business, acquired from Nestlé, suffered from significant underinvestment in maintenance and operational improvements [2] - It is alleged that Perrigo needed to make substantial capital and operational expenditures beyond previously stated cost estimates to remediate issues in the infant formula business [2] - The complaint states that there were significant manufacturing deficiencies in the facility for the infant formula business [2] - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were overstated [2] - The positive statements made by the defendants regarding the Company's business and prospects were materially misleading and lacked a reasonable basis [2] Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until January 16, 2026, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the top securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1] Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's acquisition of the infant formula business from Nestlé was significantly underinvested in maintenance and operational improvements [2] - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2] - The complaint states that there were significant manufacturing deficiencies in the facility related to the infant formula business [2] - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were overstated [2] - The positive statements made by the defendants regarding the Company's business and prospects were materially misleading and lacked a reasonable basis [2] Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until January 16, 2026, to request to be appointed as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff to share in any potential recovery [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has a strong track record in high-stakes securities litigation [4] - The firm has over 70 employees dedicated to serving clients and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Perrigo Company plc regarding a class action lawsuit alleging that the company made materially false and misleading statements about its infant formula business and its financial results during the specified class period [1]. Group 1: Allegations - The complaint alleges that the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs [1]. - Perrigo needed to make substantial capital and operational expenditures beyond the company's stated cost estimates to remediate the infant formula business [1]. - There were significant manufacturing deficiencies in the facility for the company's infant formula business [1]. - As a result of the aforementioned issues, the company's financial results, including earnings and cash flow, were overstated [1]. - The defendants' positive statements about the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - The class period for the lawsuit is from February 27, 2023, to November 4, 2025 [1]. - Shareholders are encouraged to register for the class action by January 16, 2026, to potentially be appointed as lead plaintiff [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [2].